Wiki-Pi

Search Results for: Influenza

1761 interactions found:

Sort by: Relevance Number of Pathways Number of Drugs Number of Diseases
Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
AKT1 and HSP90AA1 v-akt murine thymoma viral oncogene homolog 1 heat shock protein 90kDa alpha (cytosolic), class A member 1
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Signaling by FGFR in disease
  • Activation of BH3-only proteins
  • Signaling by Wnt
  • Platelet Aggregation (Plug Formation)
  • Signaling by EGFRvIII in Cancer
  • AKT phosphorylates targets in the cytosol
  • Signaling by SCF-KIT
  • Downstream signaling events of B Cell Receptor (BCR)
  • DAP12 signaling
  • Regulation of beta-cell development
  • PI3K/AKT activation
  • PI-3K cascade
  • RNF mutants show enhanced WNT signaling and proliferation
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • Signaling by PDGF
  • Downregulation of ERBB2:ERBB3 signaling
  • DAP12 interactions
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • GAB1 signalosome
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • G-protein beta:gamma signalling
  • CD28 co-stimulation
  • CD28 dependent PI3K/Akt signaling
  • Signaling by ERBB4
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Constitutive PI3K/AKT Signaling in Cancer
  • PI3K events in ERBB4 signaling
  • Signaling by ERBB2
  • Activation of BAD and translocation to mitochondria
  • Signaling by EGFR
  • GPCR downstream signaling
  • Signaling by VEGF
  • AKT phosphorylates targets in the nucleus
  • Downstream signal transduction
  • Regulation of gene expression in beta cells
  • Signaling by EGFR in Cancer
  • Fc epsilon receptor (FCERI) signaling
  • PI3K/AKT Signaling in Cancer
  • Platelet activation, signaling and aggregation
  • Adaptive Immune System
  • Costimulation by the CD28 family
  • PIP3 activates AKT signaling
  • Translocation of GLUT4 to the plasma membrane
  • deactivation of the beta-catenin transactivating complex
  • VEGFA-VEGFR2 Pathway
  • Metabolism of nitric oxide
  • G beta:gamma signalling through PI3Kgamma
  • PI3K events in ERBB2 signaling
  • VEGFR2 mediated vascular permeability
  • Downstream signaling of activated FGFR
  • Programmed Cell Death
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • eNOS activation and regulation
  • Intrinsic Pathway for Apoptosis
  • Butyrate Response Factor 1 (BRF1) destabilizes mRNA
  • Innate Immune System
  • Signalling by NGF
  • CTLA4 inhibitory signaling
  • AKT-mediated inactivation of FOXO1A
  • Integrin alphaIIb beta3 signaling
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Negative regulation of the PI3K/AKT network
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Signaling by FGFR
  • eNOS activation
  • TCF dependent signaling in response to WNT
  • KSRP destabilizes mRNA
  • GPVI-mediated activation cascade
  • Signaling by WNT in cancer
  • HSF1 activation
  • Regulatory RNA pathways
  • Signaling by EGFRvIII in Cancer
  • Regulation of PLK1 Activity at G2/M Transition
  • Influenza Life Cycle
  • Influenza Viral RNA Transcription and Replication
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Uptake and actions of bacterial toxins
  • EPH-Ephrin signaling
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • Recruitment of mitotic centrosome proteins and complexes
  • Regulation of actin dynamics for phagocytic cup formation
  • vRNP Assembly
  • Influenza Infection
  • Signaling by ERBB2
  • Signaling by VEGF
  • Signaling by EGFR in Cancer
  • Sema3A PAK dependent Axon repulsion
  • Mitotic G2-G2/M phases
  • Uptake and function of diphtheria toxin
  • PIWI-interacting RNA (piRNA) biogenesis
  • Organelle biogenesis and maintenance
  • Axon guidance
  • Attenuation phase
  • G2/M Transition
  • VEGFA-VEGFR2 Pathway
  • HSF1-dependent transactivation
  • EPHA-mediated growth cone collapse
  • Metabolism of nitric oxide
  • VEGFR2 mediated vascular permeability
  • Loss of Nlp from mitotic centrosomes
  • Scavenging by Class F Receptors
  • eNOS activation and regulation
  • Innate Immune System
  • Semaphorin interactions
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • Assembly of the primary cilium
  • Cellular response to heat stress
  • Anchoring of the basal body to the plasma membrane
  • Cell Cycle, Mitotic
  • eNOS activation
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Centrosome maturation
  • Constitutive Signaling by EGFRvIII
  • Adenosine triphosphate
  • Arsenic trioxide
  • Inositol 1,3,4,5-Tetrakisphosphate
  • N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
  • 5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine
  • Rifabutin
  • Nedocromil
  • 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine
  • Geldanamycin
  • 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
  • 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine
  • 4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid
  • 17-Dmag
  • 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
  • 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine
  • Adenosine-5\'-Diphosphate
  • 9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine
  • 4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole
  • 9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine
  • 9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine
  • 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
  • 8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine
  • 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
  • N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
  • N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
  • 4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE
  • 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE
  • 2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide
  • 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
  • (3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one
  • 6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE
  • 3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE
  • N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE
  • 4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol
  • 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL
  • 4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol
  • 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE
  • 4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine
  • (5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime
  • 8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-
  • 4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol
  • 2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol
  • 2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide
  • 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine
  • 4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine
  • 3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE
  • 2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE
AKT2 and HSP90AA1 v-akt murine thymoma viral oncogene homolog 2 heat shock protein 90kDa alpha (cytosolic), class A member 1
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Signaling by FGFR in disease
  • Activation of BH3-only proteins
  • mTOR signalling
  • Signaling by Wnt
  • Activation of PKB
  • Signaling by EGFRvIII in Cancer
  • AKT phosphorylates targets in the cytosol
  • Signaling by SCF-KIT
  • Downstream signaling events of B Cell Receptor (BCR)
  • DAP12 signaling
  • Regulation of beta-cell development
  • PI3K/AKT activation
  • PI-3K cascade
  • RNF mutants show enhanced WNT signaling and proliferation
  • PDE3B signalling
  • PKB-mediated events
  • PI3K Cascade
  • Signaling by PDGF
  • Downregulation of ERBB2:ERBB3 signaling
  • DAP12 interactions
  • GAB1 signalosome
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • G-protein beta:gamma signalling
  • CD28 co-stimulation
  • CD28 dependent PI3K/Akt signaling
  • PDE3B signalling
  • Signaling by ERBB4
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Constitutive PI3K/AKT Signaling in Cancer
  • PI3K events in ERBB4 signaling
  • Signaling by ERBB2
  • Activation of BAD and translocation to mitochondria
  • Signaling by EGFR
  • GPCR downstream signaling
  • Signaling by VEGF
  • AKT phosphorylates targets in the nucleus
  • Downstream signal transduction
  • Regulation of gene expression in beta cells
  • Signaling by EGFR in Cancer
  • Fc epsilon receptor (FCERI) signaling
  • PI3K/AKT Signaling in Cancer
  • Platelet activation, signaling and aggregation
  • Adaptive Immune System
  • Inhibition of TSC complex formation by PKB
  • Activation of PKB
  • Costimulation by the CD28 family
  • IRS-mediated signalling
  • PIP3 activates AKT signaling
  • mTOR signalling
  • Translocation of GLUT4 to the plasma membrane
  • IGF1R signaling cascade
  • deactivation of the beta-catenin transactivating complex
  • VEGFA-VEGFR2 Pathway
  • IRS-related events triggered by IGF1R
  • G beta:gamma signalling through PI3Kgamma
  • PI3K events in ERBB2 signaling
  • VEGFR2 mediated vascular permeability
  • Downstream signaling of activated FGFR
  • Programmed Cell Death
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Intrinsic Pathway for Apoptosis
  • Signaling by Insulin receptor
  • Innate Immune System
  • Signalling by NGF
  • Insulin receptor signalling cascade
  • CTLA4 inhibitory signaling
  • AKT-mediated inactivation of FOXO1A
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • IRS-related events
  • NGF signalling via TRKA from the plasma membrane
  • Negative regulation of the PI3K/AKT network
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Inhibition of TSC complex formation by PKB
  • Signaling by FGFR
  • IRS-mediated signalling
  • TCF dependent signaling in response to WNT
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • GPVI-mediated activation cascade
  • Signaling by WNT in cancer
  • PKB-mediated events
  • PI3K Cascade
  • HSF1 activation
  • Regulatory RNA pathways
  • Signaling by EGFRvIII in Cancer
  • Regulation of PLK1 Activity at G2/M Transition
  • Influenza Life Cycle
  • Influenza Viral RNA Transcription and Replication
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Uptake and actions of bacterial toxins
  • EPH-Ephrin signaling
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • Recruitment of mitotic centrosome proteins and complexes
  • Regulation of actin dynamics for phagocytic cup formation
  • vRNP Assembly
  • Influenza Infection
  • Signaling by ERBB2
  • Signaling by VEGF
  • Signaling by EGFR in Cancer
  • Sema3A PAK dependent Axon repulsion
  • Mitotic G2-G2/M phases
  • Uptake and function of diphtheria toxin
  • PIWI-interacting RNA (piRNA) biogenesis
  • Organelle biogenesis and maintenance
  • Axon guidance
  • Attenuation phase
  • G2/M Transition
  • VEGFA-VEGFR2 Pathway
  • HSF1-dependent transactivation
  • EPHA-mediated growth cone collapse
  • Metabolism of nitric oxide
  • VEGFR2 mediated vascular permeability
  • Loss of Nlp from mitotic centrosomes
  • Scavenging by Class F Receptors
  • eNOS activation and regulation
  • Innate Immune System
  • Semaphorin interactions
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • Assembly of the primary cilium
  • Cellular response to heat stress
  • Anchoring of the basal body to the plasma membrane
  • Cell Cycle, Mitotic
  • eNOS activation
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Centrosome maturation
  • Constitutive Signaling by EGFRvIII
  • N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide
  • 4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE
  • ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE
  • (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE
  • Rifabutin
  • Nedocromil
  • 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine
  • Geldanamycin
  • 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
  • 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine
  • 4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid
  • 17-Dmag
  • 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
  • 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine
  • Adenosine-5\'-Diphosphate
  • 9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine
  • 4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole
  • 9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine
  • 9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine
  • 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
  • 8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine
  • 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
  • N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
  • N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
  • 4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE
  • 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE
  • 2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide
  • 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
  • (3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one
  • 6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE
  • 3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE
  • N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE
  • 4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol
  • 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL
  • 4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol
  • 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE
  • 4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine
  • (5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime
  • 8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-
  • 4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol
  • 2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol
  • 2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide
  • 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine
  • 4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine
  • 3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE
  • 2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE
ABCD1 and RPSA ATP-binding cassette, sub-family D (ALD), member 1 ribosomal protein SA
  • alpha-linolenic acid (ALA) metabolism
  • ABC-family proteins mediated transport
  • Metabolism of lipids and lipoproteins
  • alpha-linolenic (omega3) and linoleic (omega6) acid metabolism
  • Linoleic acid (LA) metabolism
  • Beta-oxidation of very long chain fatty acids
  • ABCA transporters in lipid homeostasis
  • Peroxisomal lipid metabolism
  • Nonsense-Mediated Decay (NMD)
  • Translation initiation complex formation
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Ribosomal scanning and start codon recognition
  • Formation of the ternary complex, and subsequently, the 43S complex
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
ALDH2 and RPL13A aldehyde dehydrogenase 2 family (mitochondrial) ribosomal protein L13a
  • Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)
  • Metabolic disorders of biological oxidation enzymes
  • Ethanol oxidation
  • Phase 1 - Functionalization of compounds
  • Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)
  • Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)
  • Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)
  • Biological oxidations
  • Serotonin clearance from the synaptic cleft
  • Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)
  • Defective FMO3 causes Trimethylaminuria (TMAU)
  • Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)
  • Metabolism of serotonin
  • Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)
  • Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)
  • Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)
  • Defective CYP1B1 causes Glaucoma
  • Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)
  • Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)
  • Defective CYP19A1 causes Aromatase excess syndrome (AEXS)
  • Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)
  • Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)
  • Neurotransmitter Clearance In The Synaptic Cleft
  • Defective MAOA causes Brunner syndrome (BRUNS)
  • Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)
  • Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)
  • Transmission across Chemical Synapses
  • Nonsense-Mediated Decay (NMD)
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • NADH
  • Guanidine
  • Disulfiram
  • Nicotinamide-Adenine-Dinucleotide
  • Daidzin
  • Crotonaldehyde
AMFR and KPNB1 autocrine motility factor receptor, E3 ubiquitin protein ligase karyopherin (importin) beta 1
  • Metabolism of lipids and lipoproteins
  • ISG15 antiviral mechanism
  • Nuclear import of Rev protein
  • HIV Infection
  • Interferon Signaling
  • Apoptotic execution phase
  • Host Interactions of HIV factors
  • Cytokine Signaling in Immune system
  • Interactions of Rev with host cellular proteins
  • Influenza Infection
  • Antiviral mechanism by IFN-stimulated genes
  • Influenza Life Cycle
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Activation of DNA fragmentation factor
  • Transport of Ribonucleoproteins into the Host Nucleus
  • Apoptosis induced DNA fragmentation
  • Programmed Cell Death
SLC25A6 and VIM solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 vimentin
  • Integration of energy metabolism
  • Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization
  • HIV Infection
  • Regulation of insulin secretion
  • Host Interactions of HIV factors
  • Mitochondrial protein import
  • Host Interactions with Influenza Factors
  • Influenza Infection
  • Influenza Virus Induced Apoptosis
  • Interactions of Vpr with host cellular proteins
  • Apoptotic cleavage of cellular proteins
  • Striated Muscle Contraction
  • Programmed Cell Death
  • Apoptotic execution phase
  • Caspase-mediated cleavage of cytoskeletal proteins
  • Clodronate
SLC25A6 and NOTCH2NL solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 notch 2 N-terminal like
  • Integration of energy metabolism
  • Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization
  • HIV Infection
  • Regulation of insulin secretion
  • Host Interactions of HIV factors
  • Mitochondrial protein import
  • Host Interactions with Influenza Factors
  • Influenza Infection
  • Influenza Virus Induced Apoptosis
  • Interactions of Vpr with host cellular proteins
  • Clodronate
SLC25A6 and KARS solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 lysyl-tRNA synthetase
  • Integration of energy metabolism
  • Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization
  • HIV Infection
  • Regulation of insulin secretion
  • Host Interactions of HIV factors
  • Mitochondrial protein import
  • Host Interactions with Influenza Factors
  • Influenza Infection
  • Influenza Virus Induced Apoptosis
  • Interactions of Vpr with host cellular proteins
  • Cytosolic tRNA aminoacylation
  • tRNA Aminoacylation
  • Mitochondrial tRNA aminoacylation
  • Clodronate
  • L-Lysine
SLC25A6 and MID2 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 midline 2
  • Integration of energy metabolism
  • Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization
  • HIV Infection
  • Regulation of insulin secretion
  • Host Interactions of HIV factors
  • Mitochondrial protein import
  • Host Interactions with Influenza Factors
  • Influenza Infection
  • Influenza Virus Induced Apoptosis
  • Interactions of Vpr with host cellular proteins
  • Clodronate
SLC25A6 and TRIP6 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 thyroid hormone receptor interactor 6
  • Integration of energy metabolism
  • Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization
  • HIV Infection
  • Regulation of insulin secretion
  • Host Interactions of HIV factors
  • Mitochondrial protein import
  • Host Interactions with Influenza Factors
  • Influenza Infection
  • Influenza Virus Induced Apoptosis
  • Interactions of Vpr with host cellular proteins
  • Clodronate
SLC25A6 and MTUS2 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 microtubule associated tumor suppressor candidate 2
  • Integration of energy metabolism
  • Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization
  • HIV Infection
  • Regulation of insulin secretion
  • Host Interactions of HIV factors
  • Mitochondrial protein import
  • Host Interactions with Influenza Factors
  • Influenza Infection
  • Influenza Virus Induced Apoptosis
  • Interactions of Vpr with host cellular proteins
  • Clodronate
SLC25A6 and KRTAP4-12 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 keratin associated protein 4-12
  • Integration of energy metabolism
  • Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization
  • HIV Infection
  • Regulation of insulin secretion
  • Host Interactions of HIV factors
  • Mitochondrial protein import
  • Host Interactions with Influenza Factors
  • Influenza Infection
  • Influenza Virus Induced Apoptosis
  • Interactions of Vpr with host cellular proteins
  • Clodronate
SLC25A6 and STRN4 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 striatin, calmodulin binding protein 4
  • Integration of energy metabolism
  • Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization
  • HIV Infection
  • Regulation of insulin secretion
  • Host Interactions of HIV factors
  • Mitochondrial protein import
  • Host Interactions with Influenza Factors
  • Influenza Infection
  • Influenza Virus Induced Apoptosis
  • Interactions of Vpr with host cellular proteins
  • Clodronate
SLC25A6 and KRT31 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 keratin 31, type I
  • Integration of energy metabolism
  • Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization
  • HIV Infection
  • Regulation of insulin secretion
  • Host Interactions of HIV factors
  • Mitochondrial protein import
  • Host Interactions with Influenza Factors
  • Influenza Infection
  • Influenza Virus Induced Apoptosis
  • Interactions of Vpr with host cellular proteins
  • Clodronate
SLC25A6 and TEKT4 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 tektin 4
  • Integration of energy metabolism
  • Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization
  • HIV Infection
  • Regulation of insulin secretion
  • Host Interactions of HIV factors
  • Mitochondrial protein import
  • Host Interactions with Influenza Factors
  • Influenza Infection
  • Influenza Virus Induced Apoptosis
  • Interactions of Vpr with host cellular proteins
  • Clodronate
SLC25A6 and CHGB solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 chromogranin B (secretogranin 1)
  • Integration of energy metabolism
  • Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization
  • HIV Infection
  • Regulation of insulin secretion
  • Host Interactions of HIV factors
  • Mitochondrial protein import
  • Host Interactions with Influenza Factors
  • Influenza Infection
  • Influenza Virus Induced Apoptosis
  • Interactions of Vpr with host cellular proteins
  • Clodronate
SLC25A6 and LZTS2 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 leucine zipper, putative tumor suppressor 2
  • Integration of energy metabolism
  • Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization
  • HIV Infection
  • Regulation of insulin secretion
  • Host Interactions of HIV factors
  • Mitochondrial protein import
  • Host Interactions with Influenza Factors
  • Influenza Infection
  • Influenza Virus Induced Apoptosis
  • Interactions of Vpr with host cellular proteins
  • Clodronate
SLC25A6 and TRAF1 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 TNF receptor-associated factor 1
  • Integration of energy metabolism
  • Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization
  • HIV Infection
  • Regulation of insulin secretion
  • Host Interactions of HIV factors
  • Mitochondrial protein import
  • Host Interactions with Influenza Factors
  • Influenza Infection
  • Influenza Virus Induced Apoptosis
  • Interactions of Vpr with host cellular proteins
  • Clodronate
SLC25A6 and PRSS23 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 protease, serine, 23
  • Integration of energy metabolism
  • Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization
  • HIV Infection
  • Regulation of insulin secretion
  • Host Interactions of HIV factors
  • Mitochondrial protein import
  • Host Interactions with Influenza Factors
  • Influenza Infection
  • Influenza Virus Induced Apoptosis
  • Interactions of Vpr with host cellular proteins
  • Clodronate
SLC25A6 and PLSCR1 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 phospholipid scramblase 1
  • Integration of energy metabolism
  • Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization
  • HIV Infection
  • Regulation of insulin secretion
  • Host Interactions of HIV factors
  • Mitochondrial protein import
  • Host Interactions with Influenza Factors
  • Influenza Infection
  • Influenza Virus Induced Apoptosis
  • Interactions of Vpr with host cellular proteins
  • Clodronate

Page 8 out of 89 pages